US uye Europe Dhiyabhorosi Dhiyabhorosi Dhiyabhorosi Yakaitwa Glucosamine
Panyaya yeAmerican College of Rheumatology Annual Scientific Meeting (2005), inoguma nemitambo miviri yeglucosamine yakaiswa. Migumisiro yematambudziko maviri ainyanya kutarisirwa nevatsvakurudzi, vanachiremba, uye varwere vakanga vachitsvaka kugutsikana kuti glucosamine yaiva nzira yakakodzera yekurapa yeArthritis .
- GAIT (Glucosamine / Chondroitin Arthritis Intervention Trial) yakabhadharwa neNational Institutes of Health uye yakagadzirirwa kugadzirisa kuchengetedzwa nekubudirira ne glucosamine uye chondroitin , yakatorwa zvakasiyana kana pamwe chete.
- CHIKAMU (Glucosamine Unum In Die Efficacy) yaiva yeEuropean clinic trial.
GAIT (Glucosamine / Chondroitin Arthritis Intervention Trial) Phase I
Muna GAIT (Glucosamine / Chondroitin Arthritis Intervention Trial), vanenge 1 600 varwere vane marwadzo anogunun'una mabvi avo vakanyorerwa kubva ku16 masangano eUnited States rheumatology for the study. Vadzidzi vaidzidza vakanga vaona kurwadziwa kwemabvi makuru uye vaiva ne -x-ray uchapupu hwemabvi osteoarthritis. Munguva yekudzidza kweG GA, varwere:
- Akaongororwa kutanga kwekudzidza.
- Akaongororwa pamasvondo 4, 8, 16, 24.
- Varwere vakanga vasingagadziriswi kugamuchira glucosamine HCl, sodium chondroitin sulfate, zvose zvinowedzera, celecoxib (zita rechiratidzo Celebrex) , kana placebo.
- Varwere vakabvumirwa kusvika 4 000 mg zuva rimwe nerimwe reAcetaminophen.
Mhinduro kubva kuG GAIT (Glucosamine / Chondroitin Arthritis Intervention Trial)
- Mhinduro yakaratidza kuti kusanganiswa kweglucosamine uye chondroitin zviri nani kupfuura placebo asi zvinobatsira zvinoratidzika zvichienderana nekuoma kwemarwadzo.
- Mune varwere vane uwandu hwemapfupa ehutano-e-osteoarthritis, 79.2% kutora glucosamine / chondroitin kusangana kunosangana nemarwadzo ekurwadziwa.
- Kune varwere vanotora celecoxib, 69.4% vane kurwadziwa kunorwadziwa. Pane varwere vanotora glucosamine voga, 65.7% vakawana ruzivo, sezvakaita 61.4% yevarwere vanotora chondroitin voga. Uyewo, 54,3% kutora placebo kunotaura kuzorodzwa kunorwadza.
- Mune varwere vane kurwadziwa kwemafupa osteoarthritis, glucosamine / chondroitin kusanganiswa kwaisakosha zvikuru kupfuura placebo.
GUIDE (Glucosamine Unum In Die Efficacy)
Paiva nevarwere 318 muGURU rekudzidza ne knee osteoarthritis (88% vakadzi). Varwere vakanga vasinganzwisisiki kutora kana muromo glucosamine sulfate soluble powder (1500 mg kamwe pazuva), acetaminophen (1000 mg katatu pazuva), kana kuti placebo kwemwedzi mitanhatu. Mapoka ose aibvumidzwa kutora ibuprofen sezvaidiwa.
Migumisiro Inobva Kubhuku Rinodiwa (Glucosamine Unum In Die Efficacy)
- Zvose glucosamine sulfate uye acetaminophen dzaive dzakanyatsobatsira mukuderedza kurwadziwa kupfuura placebo.
- Varwere vanotora glucosamine sulfate vakaratidza humwe hutano kupfuura varwere vari kuacetaminophen.
- Zvakagumiswa kuti kamwe-zuva rimwe nerimwe 1500 mg manyore omuromo we glucosamine sulphate ingangodaro inoshandiswa kurapwa kwemafupa osteoarthritis.
Phase II uye Phase III GAIT Results
Migumisiro inobva muchikamu chechipiri chekudzidza kweGGIT yakabudiswa mumagazini yeArthritis & Rheumatism muna 2008. Phase II yakarongedza kusanganiswa kweglucosamine uye chondroitin nekuda kwekudzivirira kuwirirana kwemabvi. Kusanganiswa kweglucosamine uye chondroitin kwaiita sechisina kubudirira mukudzivirira kubatana kwekubatana kunobatanidza osteoarthritis kupfuura placebo.
Vadzidzi vadzidza avo vakarasikirwa nekawandu kwekubatana kwemazana kwemakore maviri vaiva pakati pemapoka avo vakatora glucosamine kana chondroitin voga. Zvichida, kutora iyo miviri yekuwedzera pamwe kunobata kukanganisa, izvo zvingangodaro kubudirira kwekugadzirisa kwezvinowedzera kana zvichishandiswa pamwe chete.
Phase III, iyo yaifunga kwemakore mana emadhaka, yakaratidza kuti zviyamupinyi zvakasanganiswa kana sega zvaisava nemubhadharo mukuru mukurwadziwa kwemabvi kudarika celecoxib kana placebo. Migumisiro yakabudiswa muna 2010 mubhuku reAnals of Rheumatic Disease .
Nyaya yeGlucosamine
- Musati maedza glucosamine / chondroitin kurukuriranei nachiremba wenyu uye mubvunze kuti ingapindirana sei nemurongwa wenyu wekurapa ikozvino.
- Gara pane zvamakarayirwa mishonga. Zvigadzirwa hazvisi kutora mishonga yako yakatemwa.
- Dzidza nezve glucosamine nekuita iwe tsvakurudzo yako. Tsvaga zvinyorwa zvemashoko izvo zvinovimbika.
- Tevedzera mazano anotsanangurwa nemudzidzi wekuwedzera kana kumbira chiremba wako pamusoro pemutero wakakodzera.
- Dzivisa kubatanidza zvimwe zvakasiyana-siyana zvinowedzera.
- Tenga kubva kune anonyadzisa mugadziri. Ziva zvauri kuwana.
The Bottom Line
Muna 2012, The American College of Rheumatology yakabudisa mazano ekurapa kweasteoarthritis. Mune mirayiridzo, chondroitin kana glucosamine yakanga isina kukurudzirwa kutanga kurapa kwewasteoarthritis. Chondroitin uye glucosamine inowedzera yoga kana pamwe chete inogona kunge isiri mushonga unoshanda kuvarwere vose. Inogona kushanda kune vamwe varwere, uye kana ikakushandira iwe, ramba uchirapa - inonzi yakachengeteka.
Sources:
Mhinduro ye glucosamine uye / kana chondroitin sulfate pakufambira kwebvio osteoarthritis: mushumo unobva glucosamine / chondroitin arthritis kupinda muedzo. Sawitzke et al. Arthritis & Rheumatism. 2008 Oct; 58 (10): 3183-91.
http://www.ncbi.nlm.nih.gov/pubmed/18821708
Glucosamine / Chondroitin Arthritis Intervention Trial (GAIT). NIH. Takashandurwa munaJanuary 2012.
https://nccih.nih.gov/research/results/gait
Clinical effectiveness uye kuchengetedzwa kweglucosamine, chondroitin sulphate, kusangana kwavo, celecoxib kana placebo kutorwa kurapa osteoarthritis yemabvi: zvibereko zvemakore maviri kubva kuG GAIT. June 2010. Annals weRheumatic Disease. 2010; 69: 1459-1464
http://ard.bmj.com/content/69/8/1459.abstract?sid=fc95aeb7-1d79-4a79-9dac-c65916ca2125
Mazano ekushandiswa kweAinpharmacologic uye Pharmacologic Therapies muOsteoarthritis yeHoko, Hip, uye Knee.American College yeRheumatology 2012. (Arthritis Care & Research Vol. 64, No. 4, April 2012, mapeji 465-474.)